Alex MacKerell, PhD, SilcsBio Co-founder & CSO, Co-Leads Study on Use of SILCS Technology to Improve Lung Disease Treatments
Article in Proceedings of the National Academy of Sciences illustrates use of SILCS mapping technology to improve treatments for asthma and chronic obstructive pulmonary disease December 14, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder [...]
Job Opening: Scientist – Medicinal Chemistry and Computational Design
Position: Scientist – Medicinal Chemistry and Computational Design What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management team, the operators, and the entrepreneurs. We do not write checks and just pop in for board meetings. We show up to our [...]
SilcsBio and Helix BioStructures Launch Partnership to Collaborate in Fueling Pharmaceutical Drug Design Opportunities
SilcsBio and Helix BioStructures to tap mutual areas of expertise in drug design to spur new drug design opportunities for pharmaceutical and research organizations August 29, 2022, Baltimore, MD and Indianapolis, IN – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced [...]
